• 314 Citations
  • 10 h-Index
19992019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jidong Shan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications

  • 314 Citations
  • 10 h-Index
  • 14 Article

Cytogenetic, genomic, and functional characterization of pituitary gonadotrope cell lines

Ruf-Zamojski, F., Ge, Y., Pincas, H., Shan, J., Song, Y., Hines, N., Kelley, K., Montagna, C., Nair, P., Toufaily, C., Bernard, D. J., Mellon, P. L., Nair, V., Turgeon, J. L. & Sealfon, S. C., May 1 2019, In : Journal of the Endocrine Society. 3, 5, p. 902-920 19 p.

Research output: Contribution to journalArticle

Open Access
  • 2 Scopus citations

    Genetic variants associated with FDNY WTC-related sarcoidosis

    Cleven, K. L., Ye, K., Zeig-Owens, R., Hena, K. M., Montagna, C., Shan, J., Hosgood, H. D., Jaber, N., Weiden, M. D., Colbeth, H. L., Goldfarb, D. G., Spivack, S. D. & Prezant, D. J., May 2 2019, In : International journal of environmental research and public health. 16, 10, 1830.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations

    Deletion size analysis of 1680 22q11.2DS subjects identifies a new recombination hotspot on chromosome 22q11.2

    on behalf of the International Chromosome 22q11.2, International 22q11.2 Brain and Behavior Consortia, Apr 1 2018, In : Human molecular genetics. 27, 7, p. 1150-1163 14 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations

    Safety and efficacy of Osimertinib in the treatment of a patient with metastatic lung cancer and concurrent somatic EGFR L858R and germline EGFR T790M mutations

    Ma, W., Gong, J., Shan, J., Lewis, D., Xiao, W., Moore, E. H., Zhang, Y., Hung, J., Mans, N. Z., Wei, S., Welborn, J., Stollenwerk, N. S., Lam, K. S. & Li, T., Jan 1 2018, In : JCO Precision Oncology. 2

    Research output: Contribution to journalArticle

    1 Scopus citations

    RICTOR amplification defines a novel subset of patients with lung cancer who may benefit from treatment with mTORC1/2 inhibitors

    Cheng, H., Zou, Y., Ross, J. S., Wang, K., Liu, X., Halmos, B., Ali, S. M., Liu, H., Verma, A., Montagna, C., Chachoua, A., Goel, S., Schwartz, E. L., Zhu, C., Shan, J., Yu, Y., Gritsman, K., Yelensky, R., Lipson, D., Otto, G. & 5 others, Hawryluk, M., Stephens, P. J., Miller, V. A., Piperdi, B. & Perez-Soler, R., Dec 2015, In : Cancer discovery. 5, 12, p. 1262-1270 9 p.

    Research output: Contribution to journalArticle

  • 45 Scopus citations